PMID- 30891154 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20201001 IS - 1948-9358 (Print) IS - 1948-9358 (Electronic) IS - 1948-9358 (Linking) VI - 10 IP - 3 DP - 2019 Mar 15 TI - Targeted genotyping for the prediction of celiac disease autoimmunity development in patients with type 1 diabetes and their family members. PG - 189-199 LID - 10.4239/wjd.v10.i3.189 [doi] AB - BACKGROUND: Patients with type 1 diabetes (T1D) and their first-degree relatives (FDRs) have an increased risk of developing celiac disease (CD) compared to the general population. This is largely explained by the shared association with major histocompatibility class II human leukocyte antigen (HLA) DQ2 and/or DQ8 between the two disease states. AIM: To describe the frequency of CD autoimmunity (CDA) and the distribution of HLA and haptoglobin genotypes in patients with T1D and their FDRs. Additionally, we aimed at identifying predictors associated with an increased risk of developing CDA in patients with T1D and their family members. METHODS: We obtained clinical information and blood samples from 1027 participants (302 with T1D and 725 FDRs) over a five-year period. Samples were tested for autoantibodies associated with CD, HLA-DQ alleles, and haptoglobin genotype. We fit univariate and multiple logistic regression models for CDA separately for subjects with T1D and for FDRs of subjects with T1D. RESULTS: Implementation of a screening program increased the frequency of CDA by 2-fold in participants with T1D and 2.8-fold in their FDRs. Multivariate analysis found that, in participants with T1D, having both DR7-DQ2 and DR4-DQ8 was associated with an increased frequency of CDA. In FDRs of T1D patients, reported CD in the family was associated with an increased frequency of CDA during screening. Haptoglobin 2 genotype was not associated with developing CDA in the multivariate analysis. CONCLUSION: Patients with T1D and their FDRs have a high frequency of CDA. Carrying both DR7-DQ2 and DR4-DQ8 was associated with development of CDA in patients with T1D. FAU - Leonard, Maureen M AU - Leonard MM AD - Mucosal Immunology and Biology Research Center, Mass General Hospital for Children, Boston, MA 02115, United States. FAU - Camhi, Stephanie AU - Camhi S AD - Mucosal Immunology and Biology Research Center, Mass General Hospital for Children, Boston, MA 02115, United States. FAU - Kenyon, Victoria AU - Kenyon V AD - Mucosal Immunology and Biology Research Center, Mass General Hospital for Children, Boston, MA 02115, United States. FAU - Betensky, Rebecca A AU - Betensky RA AD - Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA 02115, United States. FAU - Sturgeon, Craig AU - Sturgeon C AD - Mucosal Immunology and Biology Research Center, Mass General Hospital for Children, Boston, MA 02115, United States. FAU - Yan, Shu AU - Yan S AD - Mucosal Immunology and Biology Research Center, Mass General Hospital for Children, Boston, MA 02115, United States. FAU - Fasano, Alessio AU - Fasano A AD - Mucosal Immunology and Biology Research Center, Mass General Hospital for Children, Boston, MA 02115, United States. LA - eng GR - F32 DK109620/DK/NIDDK NIH HHS/United States GR - P30 DK040561/DK/NIDDK NIH HHS/United States PT - Journal Article PL - United States TA - World J Diabetes JT - World journal of diabetes JID - 101547524 PMC - PMC6422857 OTO - NOTNLM OT - Coeliac OT - Diabetic OT - Gluten OT - Haptoglobin OT - Human leukocyte antigen OT - Screening COIS- Conflict-of-interest statement: The authors declare no conflict of interest. EDAT- 2019/03/21 06:00 MHDA- 2019/03/21 06:01 PMCR- 2019/03/15 CRDT- 2019/03/21 06:00 PHST- 2019/02/06 00:00 [received] PHST- 2019/03/04 00:00 [revised] PHST- 2019/03/08 00:00 [accepted] PHST- 2019/03/21 06:00 [entrez] PHST- 2019/03/21 06:00 [pubmed] PHST- 2019/03/21 06:01 [medline] PHST- 2019/03/15 00:00 [pmc-release] AID - 10.4239/wjd.v10.i3.189 [doi] PST - ppublish SO - World J Diabetes. 2019 Mar 15;10(3):189-199. doi: 10.4239/wjd.v10.i3.189.